Monoclonal antibody ECOG performance status Adenocarcinoma Minimal residual disease Tyrosine kinase inhibitors (TKIs) Pathological stage Lymphoma Clinical stage CTCAE Cancer Maintenance chemotherapy Refractory Multiple myeloma Cellular therapy Surgical margin Definitive treatment Carcinoma Recurrence or relapse Neoadjuvant treatment Complete remission Checkpoint inhibitor Benign Performance status Leukemia Chemotherapy Cure TNM staging system Tumor PET scan Liquid tumor Active surveillance Partial remission Sarcoma Palliation Grade 3, 4, or 5 Complementary therapy Adjuvant treatment Antibody drug conjugate Monoclonal antibody ECOG performance status Adenocarcinoma Minimal residual disease Tyrosine kinase inhibitors (TKIs) Pathological stage Lymphoma Clinical stage CTCAE Cancer Maintenance chemotherapy Refractory Multiple myeloma Cellular therapy Surgical margin Definitive treatment Carcinoma Recurrence or relapse Neoadjuvant treatment Complete remission Checkpoint inhibitor Benign Performance status Leukemia Chemotherapy Cure TNM staging system Tumor PET scan Liquid tumor Active surveillance Partial remission Sarcoma Palliation Grade 3, 4, or 5 Complementary therapy Adjuvant treatment Antibody drug conjugate
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Monoclonal antibody
ECOG performance status
Adenocarcinoma
Minimal residual disease
Tyrosine kinase inhibitors (TKIs)
Pathological stage
Lymphoma
Clinical stage
CTCAE
Cancer
Maintenance chemotherapy
Refractory
Multiple myeloma
Cellular therapy
Surgical margin
Definitive treatment
Carcinoma
Recurrence or relapse
Neoadjuvant treatment
Complete remission
Checkpoint inhibitor
Benign
Performance status
Leukemia
Chemotherapy
Cure
TNM staging system
Tumor
PET scan
Liquid tumor
Active surveillance
Partial remission
Sarcoma
Palliation
Grade 3, 4, or 5
Complementary therapy
Adjuvant treatment
Antibody drug conjugate